Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 25 09:33AM ET
27.94
Dollar change
-0.08
Percentage change
-0.29
%
IndexRUT P/E- EPS (ttm)-2.82 Insider Own4.12% Shs Outstand89.90M Perf Week5.00%
Market Cap2.53B Forward P/E132.00 EPS next Y0.21 Insider Trans-6.09% Shs Float86.78M Perf Month13.30%
Income-234.60M PEG- EPS next Q-0.01 Inst Own104.57% Short Float4.42% Perf Quarter49.97%
Sales774.20M P/S3.27 EPS this Y111.42% Inst Trans1.63% Short Ratio4.59 Perf Half Y29.59%
Book/sh8.40 P/B3.33 EPS next Y586.49% ROA-20.58% Short Interest3.84M Perf Year26.14%
Cash/sh1.15 P/C24.25 EPS next 5Y-8.20% ROE-29.41% 52W Range13.82 - 28.90 Perf YTD45.98%
Dividend Est.- P/FCF- EPS past 5Y- ROI-26.27% 52W High-3.32% Beta1.94
Dividend TTM- Quick Ratio1.82 Sales past 5Y4.63% Gross Margin63.25% 52W Low102.17% ATR (14)0.95
Dividend Ex-Date- Current Ratio1.99 EPS Y/Y TTM-56.54% Oper. Margin-15.82% RSI (14)69.74 Volatility4.61% 3.64%
Employees2700 Debt/Eq0.19 Sales Y/Y TTM11.44% Profit Margin-30.30% Recom2.71 Target Price25.15
Option/ShortYes / Yes LT Debt/Eq0.17 EPS Q/Q57.02% Payout- Rel Volume0.06 Prev Close28.02
Sales Surprise4.49% EPS Surprise90.40% Sales Q/Q11.59% EarningsMay 07 AMC Avg Volume835.74K Price27.94
SMA208.00% SMA5014.04% SMA20034.15% Trades Volume3,040 Change-0.29%
Date Action Analyst Rating Change Price Target Change
Jun-27-24Initiated Scotiabank Sector Outperform $29
Jun-03-24Resumed Jefferies Underperform $20
May-08-24Upgrade Leerink Partners Market Perform → Outperform $25 → $35
Dec-21-23Resumed Piper Sandler Neutral $23
Dec-19-23Initiated Wells Fargo Equal Weight $20
Dec-14-23Initiated Guggenheim Buy $23
Dec-13-23Initiated Wolfe Research Outperform $28
Jul-05-23Resumed JP Morgan Underweight $18
May-23-23Upgrade Goldman Sell → Buy $18 → $25
Jan-18-23Upgrade Raymond James Mkt Perform → Outperform $25
Jul-17-24 08:00AM
Jul-15-24 02:01PM
Jul-11-24 09:00AM
Jul-10-24 07:53AM
Jul-09-24 09:00AM
09:00AM Loading…
Jul-08-24 09:00AM
Jul-03-24 07:07PM
Jul-02-24 09:00AM
Jun-24-24 04:05PM
Jun-12-24 11:46AM
Jun-11-24 09:36AM
08:00AM
Jun-06-24 11:31AM
Jun-05-24 02:35AM
Jun-04-24 09:00AM
04:05PM Loading…
Jun-03-24 04:05PM
May-30-24 05:55PM
May-23-24 06:44PM
06:00PM
May-16-24 04:05PM
02:52AM
02:52AM
May-13-24 09:45AM
May-10-24 06:00AM
May-09-24 06:55PM
May-08-24 04:28PM
03:59PM
01:54PM
01:24PM
12:15PM
03:47AM Loading…
03:47AM
May-07-24 09:56PM
07:00PM
06:02PM
05:50PM
04:47PM
04:05PM
09:00AM
Apr-30-24 04:05PM
Apr-24-24 10:01AM
Apr-17-24 08:00AM
Apr-16-24 09:15AM
Apr-11-24 10:00AM
Apr-09-24 09:10AM
08:00AM
Mar-28-24 11:30AM
Mar-27-24 07:51AM
Mar-21-24 09:40PM
Mar-20-24 04:05PM
Mar-01-24 09:41AM
Feb-28-24 02:45PM
11:24AM
10:24AM
07:50AM
Feb-27-24 07:00PM
06:30PM
04:42PM
04:05PM
09:15AM
Feb-26-24 09:16AM
Feb-21-24 04:05PM
Feb-16-24 07:05AM
Feb-15-24 04:05PM
Feb-01-24 09:25AM
Jan-30-24 05:00PM
Jan-25-24 07:05PM
Jan-22-24 08:55AM
Jan-18-24 06:10PM
Jan-09-24 04:05PM
Jan-04-24 11:10AM
Jan-03-24 04:05PM
Dec-21-23 03:05PM
09:17AM
08:30AM
Dec-20-23 08:00AM
Dec-14-23 08:22AM
Dec-06-23 11:30AM
Nov-21-23 10:54AM
Nov-20-23 04:05PM
11:18AM
Nov-16-23 04:05PM
Nov-09-23 07:00AM
Nov-08-23 09:20PM
04:10PM
Nov-07-23 02:30PM
10:24AM
10:09AM
Nov-06-23 07:00PM
04:59PM
04:36PM
04:05PM
Nov-04-23 03:02AM
Nov-03-23 07:04PM
Nov-01-23 09:00AM
Oct-31-23 04:05PM
Oct-30-23 03:46PM
Oct-26-23 08:00AM
Oct-20-23 10:31AM
Oct-09-23 06:56PM
Sep-29-23 11:44AM
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk of developing a disease later in life. The Other segment offers testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SPIEGELMAN DANIEL KDirectorJun 04 '24Sale22.053,78883,52532,917Jun 04 05:57 PM
SPIEGELMAN DANIEL KDirectorJun 03 '24Sale22.043,78883,48836,705Jun 04 05:57 PM
DIAZ PAUL JPresident and CEOMay 15 '24Sale25.0775,0001,880,4151,066,166May 15 05:49 PM
DIAZ PAUL JPresident and CEOMay 14 '24Sale25.2195,0002,394,7981,141,166May 15 05:49 PM
DIAZ PAUL JPresident and CEOMay 13 '24Sale25.1357,8441,453,5501,236,166May 15 05:49 PM
Newcomer Lee NisleyDirectorMay 13 '24Sale25.306,200156,86066,650May 15 05:48 PM
Riggsbee Richard BryanChief Financial OfficerDec 01 '23Sale19.0930,000572,835291,812Dec 05 04:19 PM
Riggsbee Richard BryanChief Financial OfficerNov 01 '23Sale15.6930,000470,622321,812Nov 03 05:12 PM